Empagliflozin Targeting STAT3/Akt/Nrf2 Axis Promoting Diabetic Wound Healing in Rat Model
September 2025
in “
Frontiers in Pharmacology
”
Studysummary In a study using diabetic rats, researchers found that oral empagliflozin accelerated wound healing by reducing inflammation and oxidative stress, indicating potential benefits beyond blood sugar control for managing diabetic wounds.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on frontiersin.org →